We are live on
!
Find out more
Syndax Pharmaceuticals
SNDX
SNDX
177 hedge funds and large institutions have $1.95B invested in Syndax Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 82 increasing their positions, 42 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
95% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 42
89% more capital invested
Capital invested by funds: $1.03B → $1.95B (+$920M)
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
10.06% more ownership
Funds ownership: 102.21% → 112.28% (+10%)
1% more funds holding
Funds holding: 175 → 177 (+2)
6% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 34
6% more call options, than puts
Call options by funds: $15.7M | Put options by funds: $14.9M
Holders
177
Holders Change
+2
Holders Change %
+1.14%
% of All Funds
2.58%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.13%
New
36
Increased
82
Reduced
42
Closed
34
Calls
$15.7M
Puts
$14.9M
Net Calls
+$819K
Net Calls Change
+$2.22M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$42.7M |
| 2 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$31.7M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$28.8M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$25.6M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$25.3M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$35.3M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
-$34.7M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$32.6M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$17.9M |
| 5 |
CC
Commodore Capital
New York
|
-$13.9M |
